Spinal Muscular Atrophy (SMA) is a genetic disease that affects nerve cells in the spinal cord. These nerve cells, called motor neurons, are responsible for controlling muscle movements. In SMA, these neurons are damaged, leading to progressive muscle weakness and ultimately the loss of muscle function.
SMA is typically categorized into different types, and one of them is Type 2. SMA Type 2 is known for symptoms emerging at a later stage compared to some other types, usually between 6 and 18 months of age. Children with SMA Type 2 may have difficulty sitting and standing, and some may require assistance with walking. They may also experience respiratory and swallowing issues.
In terms of life expectancy, the severity of SMA can vary significantly. Advances in treatment and care have significantly increased the life expectancy of individuals with SMA. Some people with SMA Type 2 can reach a normal lifespan, especially with advanced medical care and support. However, the prognosis of SMA can vary from person to person, and it is important to discuss individual cases with healthcare professionals for specific information.